EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy.
Screening for EGFR mutation is a key molecular test for management of lung cancer patients. Outcome of patients with mutation receiving EGFR tyrosine kinase inhibitor is known to be better across different ethnic populations. However, frequency of EGFR mutations and the clinical response in most oth...
Saved in:
| Main Authors: | Vanita Noronha, Kumar Prabhash, Abhishek Thavamani, Anuradha Chougule, Nilendu Purandare, Amit Joshi, Rashmi Sharma, Saral Desai, Nirmala Jambekar, Amit Dutt, Rita Mulherkar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061561&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frequency of EGFR mutations in 907 lung adenocarcioma patients of Indian ethnicity.
by: Anuradha Chougule, et al.
Published: (2013-01-01) -
Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center
by: Avinash Vijaykumar Pandey, et al.
Published: (2015-01-01) -
Prevalence of EGFR Mutations in Patients With Resected Stage I to III Nonsquamous Non–Small Cell Lung Cancer: Results of India Cohort
by: Ullas Batra, et al.
Published: (2025-04-01) -
Anti-EGFR aptamer exhibits direct anti-cancer effects in NSCLC cells harboring EGFR L858R mutations
by: Brian J. Thomas, et al.
Published: (2024-11-01) -
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India
by: Ajaykumar Singh, et al.